Cell Transplantation in Parkinson's Disease [Internet].

Technology and target group: In Parkinson's disease, the brain cells that produce dopamine die. Approximately 15,000 patients in Sweden have Parkinson's disease. In its early stages, the disease can often be treated successfully by drugs. However, in most patients the disease progresses after a few years to a stage with complications where drugs no longer have a sufficient effect. In patients with Parkinson's disease, cell transplantation is intended to replace dead brain cells. A solution containing small fragments of brain tissue is injected into the patient's brain. The results to date suggest that cell transplantation mainly benefits patients who still have a positive effect from medication but who have started to have complications. The size of this patient group in Sweden is estimated to be between 100 and 200 per year.

http://ift.tt/2wLYuHN